Search

Your search keyword '"Lorcaserin -- Research"' showing total 35 results

Search Constraints

Start Over You searched for: Descriptor "Lorcaserin -- Research" Remove constraint Descriptor: "Lorcaserin -- Research"
35 results on '"Lorcaserin -- Research"'

Search Results

1. Researchers from Brigham and Women's Hospital Report Recent Findings in Clinical Trial Research (Risk of New-onset Diabetes and Efficacy of Pharmacological Weight Loss Therapy)

2. Research on Science Published by a Researcher at Baylor College of Medicine (Neural circuits expressing the serotonin 2C receptor regulate memory in mice and humans)

3. University of Colorado Researcher Provides Details of New Studies and Findings in the Area of Veterans Health (Weight Loss Outcomes in a Veterans Affairs Pharmacotherapy-Based Weight Management Clinic)

4. Studies from Ludwig-Maximilians-University Munich in the Area of Gene Therapy Described (Targeted Molecular Strategies for Genetic Neurodevelopmental Disorders: Emerging Lessons From Dravet Syndrome)

5. Findings on Opioids Discussed by Investigators at University of Texas Health Science Center San Antonio (Interactions Between Lorcaserin and Opioids: Ventilation and Food-versus-drug Choice)

7. New Findings from U.S. Food and Drug Administration (FDA) in the Area of Toxicology Reported (Carcseq Detection of Lorcaserin-induced Clonal Expansion of pik3ca h1047r Mutants In Rat Mammary Tissue)

8. Study Results from Loma Linda University Update Understanding of Obesity (Hypothesis: Amelioration of Obesity-induced Cognitive Dysfunction Via a Lorcaserin-betahistine Combination Treatment)

9. Findings from Pusan National University Reveals New Findings on Obesity (Anti-obesity Drugs: Long-term Efficacy and Safety: an Updated Review)

10. Researchers from Mayo Clinic Describe Findings in Obesity (Selection of Antiobesity Medications Based On Phenotypes Enhances Weight Loss: a Pragmatic Trial In an Obesity Clinic)

11. Researchers from Department of Medicine Provide Details of New Studies and Findings in the Area of Veterans (Obesity Pharmacotherapy Is Effective In the Veterans Affairs Patient Population: a Local and Virtual Cohort Study)

12. New Marijuana/Cannabis Findings from Columbia University Discussed (5ht-2c Agonist Lorcaserin Decreases Cannabis Self-administration In Daily Cannabis Smokers)

13. Research on Pharmacology Discussed by Researchers at University of Malta (Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain)

14. Studies from Hospital das Clinicas Have Provided New Data on Obesity (Should the Same Safety Scrutiny of Antiobesity Medications be Applied to Other Chronic Usage Drugs?)

15. Findings from Pusan National University Yangsan Hospital Provides New Data about Obesity (Anti-Obesity Drugs: Long-Term Efficacy and Safety: An Updated Review)

16. Findings from Massachusetts General Hospital and Harvard Medical School Broaden Understanding of Fatty Liver Disease (Effect of Weight Loss Medications on Hepatic Steatosis and Steatohepatitis: A Systematic Review)

17. Lovely Professional University Researchers Add New Study Findings to Research in Applied Sciences (A Critical Review on Obesity: Herbal Approach, Bioactive Compounds, and Their Mechanism)

18. Studies from NOVA Southeastern University Provide New Data on Obesity and Diabetes (Prevalence of Antiobesity Treatment and Weight-inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes In the United States)

19. New Obesity Study Findings Have Been Reported by Investigators at Harvard University School of Medicine (Pharmacotherapy of Obesity: Available Medications and Drugs Under Investigation)

20. Findings from Kansas City Veterans Affairs Medical Center Update Knowledge of Drug Research (Biphasic Reward Effects Are Characteristic of Both Lorcaserin and Drugs of Abuse: Implications for Treatment of Substance Use Disorders)

21. RESEARCH SHOWS EMPLOYER-BASED WEIGHT MANAGEMENT PROGRAM WITH ACCESS TO ANTI-OBESITY MEDICATIONS RESULTS IN GREATER WEIGHT LOSS

22. Researchers at King Edward Medical University Publish New Study Findings on Antidiabetic Agents (The Potential Role of Metformin as a Weight Loss Drug in Non-Diabetic Individuals: A Comprehensive Review)

23. New Proinsulin Study Findings Have Been Published by Researchers at Nanjing Medical University (Lorcaserin Inhibit Glucose-Stimulated Insulin Secretion and Calcium Influx in Murine Pancreatic Islets)

24. University of Oxford Reports Findings in Antipsychotics (Interventions for preventing weight gain after smoking cessation)

25. Investigators from Mercer University Zero in on Central Nervous System Agents (Evaluation of Lorcaserin As an Anticonvulsant In Juvenile Fmr1 Knockout Mice)

26. Researchers' Work from Baylor University College of Medicine Focuses on Neuroscience (Barbadin Potentiates Long-term Effects of Lorcaserin On Pomc Neurons and Weight Loss)

27. BY MICHAEL MEZHER THE US FOOD AND DRUG ADMINISTRATION (FDA) ON THURSDAY ANNOUNCED IT HAS REQUESTED THE WITHDRAWAL OF EISAI'S WEIGHT-LOSS DRUG BELVIQ (LORCASERIN) AND THE EXTENDED RELEASE VERSION BELVIQ XR AFTER A LARGE POSTMARKETING STUDY FOUND INCREASED RATES OF PANCREATIC, COLORECTAL AND LUNG CANCER AMONG PATIENTS TAKING THE DRUG. THE ANNOUNCEMENT COMES ONE MONTH AFTER THE AGENCY ISSUED A SAFE

28. Study Data from Polish Academy of Sciences Update Understanding of Molecular Science (Chronic Lorcaserin Treatment Reverses the NicotineWithdrawal-Induced Disruptions to Behavior and Maturation in Developing Neurons in the Hippocampus of Rats)

29. Eisai starts lorcaserin phase three clinical study

30. Eisai starts lorcaserin phase three clinical study

31. Reports Outline Type 2 Diabetes Study Results from Danylo Halytsky Lviv National Medical University (The role of ghrelin and serotonin in the control of eating behavior in patients with obesity and diabetes mellitus type 2)

32. Studies from French National Center for Scientific Research - 5287 Update Current Data on Ventral Tegmental Area (Lorcaserin bidirectionally regulates dopaminergic function site-dependently and disrupts dopamine brain area correlations in rats)

33. Research Conducted at Department of Biotechnology Has Provided New Information about Biomolecule Research (Pharmacophore Directed Screening of Agonistic Natural Molecules Showing Affinity to 5HT2C Receptor)

34. Reports on Diabetes Research from University of Iowa Provide New Insights (The Bbsome In Pomc and Agrp Neurons Is Necessary for Body Weight Regulation and Sorting of Metabolic Receptors)

35. Reports Outline Obesity and Diabetes Study Results from Harvard University School of Medicine (Lorcaserin Treatment Decreases Body Weight and Reduces Cardiometabolic Risk Factors In Obese Adults: a Six-month, Randomized, Placebo-controlled, ...)

Catalog

Books, media, physical & digital resources